Clinical efficacy and safety of peginterferon beta-1a in relapsing multiple sclerosis: Data from the pivotal phase 3 advance study

Category Primary study
JournalNeurology
Year 2013
This article has no abstract
Epistemonikos ID: bea8ad597f8f425fb6f098142b57162ab1ff6fb2
First added on: Feb 05, 2025